(CN) — A federal judge has temporarily blocked an expected $4 billion slash to funding for biomedical research after a group ...

The lawsuit, filed in federal court in Boston, challenges the Trump administration, the Department of Health and Human Services and the National Institutes of Health over efforts to reduce funding ...

(CN) — A coalition of 22 state attorneys general is taking aim at a Trump administration policy that would slash funding for ...

Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

Moderna Inc. dropped its share prices by 17 percent last week to finish at $32.6 from the $39.42 registered on January 31 as ...

To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Buying stocks at significantly reduced valuations can lead to some incredible returns later on. But that doesn't mean that ...

Journal of the Academy of Public Health, whose founders include NIH and FDA nominees, goes against the grain with paid peer ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...